Solange Peters chairs medical oncology and thoracic malignancies at the University Hospital of Lausanne, Switzerland, specializing in thoracic tumors and cancer immunotherapy. She leads translational programs in collaboration with the Swiss Federal Institute of Technology and Ludwig Institute, focusing on lung cancer biomarker discovery and innovative treatment strategies. Peters is a principal investigator for lung cancer trials and holds leadership roles in the European Thoracic Oncology Platform and Paris Saclay Cancer Cluster.
